Search - tctmd.com

Displaying 41 - 60 of 1022

Sort: Relevancy | Date

Presentation NY Valves 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Didier Tchetche

June 27, 2025

Presentation NY Valves 2025

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

Presenter: Thomas Elie Modine

June 25, 2025

Presentation NY Valves 2025

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

Presenter: Pradeep K. Yadav

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Conference News ACC 2025

Cardiologists Plot Next Moves After New Board Rejected

Yael L. Maxwell

April 11, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

News Daily News

Exercise Training: The Devil’s in the Details for CAD Patients

Caitlin E. Cox

January 22, 2025

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Daily News

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

Todd Neale

November 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Advertisement

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial

SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

Cardiologists Plot Next Moves After New Board Rejected

Pi-Cardia Reports First Commercial Cases with ShortCut™

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Exercise Training: The Devil’s in the Details for CAD Patients

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

November 2024 Dispatch for the CV Team

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content